CARDLYTICS INC - NOTE 1.000% 9/1

CUSIP: 14161WAB1

Q2 2025 13F Holders as of 30 Jun 2025

Type / Class
Debt / NOTE 1.000% 9/1
Market price (% of par)
96.53%
Total 13F principal
$9,876,320
Principal change
-$5,500,000
Total reported market value
$31,163,712
Number of holders
7
Value change
-$5,351,194
Number of sells
1

Quarterly Holders Quick Answers

What is CUSIP 14161WAB1?
CUSIP 14161WAB1 identifies 14161WAB1 - CARDLYTICS INC - NOTE 1.000% 9/1 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of CARDLYTICS INC - NOTE 1.000% 9/1 as of Q2 2025

As of 30 Jun 2025, CARDLYTICS INC - NOTE 1.000% 9/1 was held by 7 institutional bondholders reporting positions in Form 13F filings. These institutions reported holding $9,876,320 in principal (par value) of the bond. The largest 7 bondholders included PenderFund Capital Management Ltd., WHITEBOX ADVISORS LLC, WELLINGTON MANAGEMENT GROUP LLP, MORGAN STANLEY, BANK OF AMERICA CORP /DE/, Context Capital Management, LLC, and Chicago Capital Management, LLC. This page lists 7 institutional bondholders reporting positions for the Q2 2025 filing period.
Investor Option Weight % Change % Value $ * Price (% of par) Principal Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.